Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02352714 · ClinicalTrials.gov registry record · Phase 4
Study of Pain Control With Hormonal IUS Insertion
A Phase 4 study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
NCT02352714 is a Phase 4 study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 98 participants.
The verdict
NCT02352714, a Phase 4 study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
Study Summary
This study aims to compare pain during insertion of the Skyla® IUS using a 100mm visual analog scale (VAS) among 92 young women aged 14 to 22 years randomized to receive a paracervical (n=46) block versus a sham paracervical block (n=46).
Interventions
- DRUG Paracervical Nerve Block
- DRUG Sham Paracervical Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2015-01 |
| Est. Completion | 2016-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02352714
The ClinicalTrials.gov registry entry for NCT02352714 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Paracervical Nerve Block is the first listed.
NCT02352714 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02352714 about?
NCT02352714 is a clinical study titled "Study of Pain Control With Hormonal IUS Insertion". This study aims to compare pain during insertion of the Skyla® IUS using a 100mm visual analog scale (VAS) among 92 young women aged 14 to 22 years randomized to receive a paracervical (n=46) block versus a sham paracervical block (n=46).
What is the current status of trial NCT02352714?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2015-01. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02352714?
The interventions under investigation include: Paracervical Nerve Block (DRUG), Sham Paracervical Block (DRUG).
Who is sponsoring clinical trial NCT02352714?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.